ERT Relocates Customer Care Team to Provide Stronger Client Support

PHILADELPHIA, June 29 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), a leading
provider of centralized ECG, ePRO, eClinical technology, and other services to
the biopharmaceutical, medical device, and related industries, is to move its
dedicated customer care team to its new state-of-the-art headquarters and
logistics operations in Philadelphia. This strategic move to expand the group
will help ERT strengthen and support its growing customer base and deliver
enhanced customer satisfaction.

ERT currently operates from three offices around the globe, with sites in
Philadelphia and New Jersey, USA and Peterborough, UK. The 30-strong customer
care team will move from its current base in Bridgewater, New Jersey, to the
new Philadelphia facility. By leveraging the resources from both the call
center and resident ECG groups, ERT will be able to provide better technical
support and customer services. This group expansion, through modifying and
merging the groups, increases internal efficiency, provides more resources to
the customer, and flexibility to address both technical and study-specific
issues.

Amy Furlong, Executive Vice President, Cardiac Safety Operations at ERT, said,
"Our Customer Care Team is an independent group that is focused on providing
24/7 support to our customers, as well as supporting our Project Management
team. Our Customer Care and Project Management teams in Philadelphia are in
constant communication. Therefore, we made a business decision to relocate our
Customer Care team to our Philadelphia offices to allow our cardiac safety
operations to be more aligned. Having both teams in a central location gives
us better coverage for our resources and brings more efficiency to both
services."

The 24/7 Customer Care team provides support to ECG investigator sites and
incoming calls on ECG equipment issues, queries on ECG data and requests for
ECG reports. Unlike many other customer support services, the ERT team
proactively contacts its customers to alert them of any potential issues. The
team also communicates with investigator sites whenever new ECG equipment is
shipped to confirm shipping timelines and alerts its customers to any changes
in the ERT system that may affect them, such as world time zone changes.

In addition to the growth of the Customer Care group, ERT has increased its
mechanism to communicate and deliver customer satisfaction by developing a new
initiative - My Study Portal(TM). This web-based interface now has many
features that are available to site investigators to provide an alternate
method of customer support for items such as re-supply ordering, query
resolution, and report retrieval in a real time basis.

My Study Portal provides users with secure 24/7 access to a centralized
environment to view and manage vital data, from anywhere in the world -- on
demand, in real time.

For further information on ERT and its technology and services, please email
info@ert.com, call +1.215.972.0420 or visit www.ert.com.

About ERT
Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a
provider of technology and services to the global biopharmaceutical and
medical device industries. The Company is the market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology and services
to evaluate cardiac safety in clinical development. The Company also provides
technology and services to streamline the clinical trials process by enabling
its customers to automate the collection, analysis, and distribution of
clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements, including, but not limited to, 2009 financial guidance,
involve a number of risks and uncertainties such as the Company's ability to
obtain new contracts and accurately estimate net revenues due to uncertain
regulatory guidance, variability in size, scope and duration of projects, and
internal issues at the sponsoring client, integration of acquisitions,
competitive factors, technological development, and market demand. As a
result, actual results may differ materially from any financial outlooks
stated herein. Further information on potential factors that could affect the
Company's financial results can be found in the Company's Reports on Form 10-K
and 10-Q filed with the Securities and Exchange Commission. The Company
undertakes no obligation to publicly update any forward-looking statement,
whether as a result of new information, future events, or otherwise.

SOURCE ERT

John Blakeley of ERT, +1-215-972-0420, jblakeley@ert.com, or, Fiona Robinson
of The Scott Partnership for ERT, +44 1477 539539, ert@scottpr.com